CpG oligonucleotides as immunotherapeutic adjuvants: innovative applications and delivery strategies
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Innovative strategies for co-delivering antigens and CpG oligonucleotides
Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles
Approaches to enhancing immune responses stimulated by CpG oligodeoxynucleotides
Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy
The immunogenicity of CpG-antigen conjugates
CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases
Use of CpG oligonucleotides in treatment of asthma and allergic disease
CpG oligodeoxynucleotide-based therapy of lymphoid malignancies
CpG oligonucleotide as an adjuvant for the treatment of prostate cancer
CpG oligonucleotides for immunotherapeutic treatment of neuroblastoma